Search research articles
Contact Us
Filters
Showing results (1-10 of 150) with videos related to
Page
of 15
Sort By:
Herpes : the Journal of the IHMF
|
August 21, 2004
Viruses and schizophrenia: a focus on herpes simplex virus
Robert Yolken
Brain, Behavior, and Immunity
|
December 23, 2016
The microbiome, immunity, and schizophrenia and bipolar disorder
Faith Dickerson, Emily Severance, Robert Yolken
Plos Neglected Tropical Diseases
|
November 7, 2017
Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia
Robert Yolken, E Fuller Torrey, Faith Dickerson
Schizophrenia Research
|
July 3, 2003
Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii
Lorraine Jones-Brando, E Fuller Torrey, Robert Yolken
Biological Psychiatry Global Open Science
|
October 26, 2023
Levels of Matrix Metalloproteinase 9 Are Elevated in Persons With Schizophrenia or Bipolar Disorder: The Role of Modifiable Factors
Faith Dickerson, Dhananjay Vaidya, Yisi Liu, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 2008
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs
Bogdana Krivogorsky, Peter Grundt, Robert Yolken, et al.
Journal of Clinical Microbiology
|
September 8, 2005
Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays
Jeremy Mauldin, Kathryn Carbone, Henry Hsu, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2006
In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin
Lorraine Jones-Brando, John D'Angelo, Gary H Posner, et al.
Schizophrenia Research
|
October 13, 2006
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia
Faith Dickerson, John Boronow, Cassie Stallings, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 30, 2007
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder
Faith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 150) with videos related to
Sort By:
Page
of 15
Herpes : the Journal of the IHMF
|
August 21, 2004
Viruses and schizophrenia: a focus on herpes simplex virus
Robert Yolken
Brain, Behavior, and Immunity
|
December 23, 2016
The microbiome, immunity, and schizophrenia and bipolar disorder
Faith Dickerson, Emily Severance, Robert Yolken
Plos Neglected Tropical Diseases
|
November 7, 2017
Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia
Robert Yolken, E Fuller Torrey, Faith Dickerson
Schizophrenia Research
|
July 3, 2003
Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii
Lorraine Jones-Brando, E Fuller Torrey, Robert Yolken
Biological Psychiatry Global Open Science
|
October 26, 2023
Levels of Matrix Metalloproteinase 9 Are Elevated in Persons With Schizophrenia or Bipolar Disorder: The Role of Modifiable Factors
Faith Dickerson, Dhananjay Vaidya, Yisi Liu, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 2008
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs
Bogdana Krivogorsky, Peter Grundt, Robert Yolken, et al.
Journal of Clinical Microbiology
|
September 8, 2005
Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays
Jeremy Mauldin, Kathryn Carbone, Henry Hsu, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2006
In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin
Lorraine Jones-Brando, John D'Angelo, Gary H Posner, et al.
Schizophrenia Research
|
October 13, 2006
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia
Faith Dickerson, John Boronow, Cassie Stallings, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 30, 2007
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder
Faith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Page
of 15